"Glucose Intolerance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.
Concept/Terms
Glucose Intolerance- Glucose Intolerance
- Glucose Intolerances
- Intolerance, Glucose
- Intolerances, Glucose
Below are MeSH descriptors whose meaning is more general than "Glucose Intolerance".
Below are MeSH descriptors whose meaning is more specific than "Glucose Intolerance".
This graph shows the total number of publications written about "Glucose Intolerance" by people in Harvard Catalyst Profiles by year, and whether "Glucose Intolerance" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 2 | 4 |
1995 | 1 | 1 | 2 |
1996 | 2 | 1 | 3 |
1997 | 1 | 1 | 2 |
1998 | 1 | 3 | 4 |
1999 | 1 | 2 | 3 |
2000 | 1 | 3 | 4 |
2001 | 2 | 0 | 2 |
2002 | 7 | 4 | 11 |
2003 | 2 | 7 | 9 |
2004 | 7 | 2 | 9 |
2005 | 5 | 7 | 12 |
2006 | 8 | 5 | 13 |
2007 | 7 | 8 | 15 |
2008 | 7 | 11 | 18 |
2009 | 4 | 7 | 11 |
2010 | 7 | 7 | 14 |
2011 | 9 | 10 | 19 |
2012 | 3 | 8 | 11 |
2013 | 14 | 6 | 20 |
2014 | 11 | 16 | 27 |
2015 | 6 | 4 | 10 |
2016 | 9 | 8 | 17 |
2017 | 14 | 10 | 24 |
2018 | 5 | 4 | 9 |
2019 | 10 | 11 | 21 |
2020 | 7 | 8 | 15 |
2021 | 9 | 4 | 13 |
2022 | 11 | 1 | 12 |
2023 | 2 | 0 | 2 |
Below are the most recent publications written about "Glucose Intolerance" by people in Profiles.
-
Are HOMA-IR and HOMA-B good predictors for diabetes and pre-diabetes subtypes? BMC Endocr Disord. 2023 Feb 14; 23(1):39.
-
Gestational Glucose Intolerance and Risk of Future Diabetes. Diabetes Care. 2023 01 01; 46(1):83-91.
-
The relationship between glucose intolerance status and risk of hospitalization during two decades of follow-up: Tehran lipid and glucose study. Ann Med. 2022 12; 54(1):3258-3268.
-
Determinants of the progression to type 2 diabetes and regression to normoglycemia in people with pre-diabetes: A population-based cohort study over ten years. Prim Care Diabetes. 2022 12; 16(6):797-803.
-
Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same? Front Endocrinol (Lausanne). 2022; 13:1041808.
-
Baseline characteristics of participants in the Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) Program. BMJ Open Diabetes Res Care. 2022 10; 10(5).
-
Post-translational control of beige fat biogenesis by PRDM16 stabilization. Nature. 2022 09; 609(7925):151-158.
-
Human CIDEC transgene improves lipid metabolism and protects against high-fat diet-induced glucose intolerance in mice. J Biol Chem. 2022 09; 298(9):102347.
-
Transcriptomic responses are sex-dependent in the skeletal muscle and liver in offspring of obese mice. Am J Physiol Endocrinol Metab. 2022 Oct 01; 323(4):E336-E353.
-
Glucose Intolerance in Pregnancy and Offspring Obesity in Late Adolescence. Diabetes Care. 2022 07 07; 45(7):1540-1548.